Cardiol Therapeutics Inc.
CRDL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001702123
No open-market purchases or sales by Cardiol Therapeutics Inc. insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $31.3M in total; no superinvestor holds it.
Holders of 5% or more of CRDL
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Cardiol Therapeutics Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| MMCAP International Inc. SPC | 13G/A | 17.60%21.3M shares | −0.30 ppfrom 17.90% | Jan 30, 20263 filings | Aug 14, 2026 | SEC |
| Tejara Capital Ltd | 13G/A | 5.30%6.38M shares | +0.10 ppfrom 5.20% | Oct 23, 20252 filings | Sep 23, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
5 Schedule 13D and 13G filings on Cardiol Therapeutics Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Sep 23, 202612:16 PM ET | Tejara Capital Ltd | 13G/A | 5.30%6.38M shares | +0.10 ppfrom 5.20% | Sep 2, 2026 | SEC |
| Aug 14, 20264:08 PM ET | MMCAP International Inc. SPCand 1 other | 13G/A | 17.60%21.3M shares | −0.30 ppfrom 17.90% | Jun 30, 2026 | SEC |
| May 15, 20264:29 PM ET | MMCAP International Inc. SPCand 1 other | 13G/A | 17.90%21.1M shares | +3.00 ppfrom 14.90% | Mar 31, 2026 | SEC |
| Jan 30, 20264:01 PM ET | MMCAP International Inc. SPCand 1 other | 13G | 14.90%17.5M shares | New | Jan 23, 2026 | SEC |
| Oct 23, 20256:43 PM ET | Tejara Capital Ltd | 13G | 5.20%5.13M shares | New | Oct 17, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Cardiol Therapeutics Inc. shares.
No Form 144 notices for Cardiol Therapeutics Inc. are on file.